BioSpace News Archive

Business

Cerveau Technologies Signs Research Agreement With Houston Methodist

Cerveau Technologies today announced an agreement with Houston Methodist Hospital to support multiple projects over the next several years.

November 8, 2017
·
2 min read
Business

The Science Center Release: These Three Startups are Simplifying and Streamlining Healthcare

Three companies aiming to simplify and streamline healthcare fields have set up shop at the The Science Center’s Port business incubator. ChromaTan, InnaMed and Group K Diagnostics are all occupying lab space at 3624 Market Street.

November 8, 2017
·
2 min read
Business

TG Therapeutics Provides Business Update and Reports Third Quarter 2017 Financial Results

Cash, cash equivalents, investment securities, and interest receivable were $91.8 million as of September 30, 2017, as compared to $86.5 million at June 30, 2017.

November 8, 2017
·
9 min read
Business

Ginolis Announces Distribution Agreement With Darwin Microfluidics for Dispensing Pumps

The distribution agreement represents a major step for Ginolis in making its’ patented dispensing technology available to researchers and scientists around the world.

November 8, 2017
·
2 min read
Genetown

Syndax to Present at the SITC 32nd Annual Scientific Meeting

Syndax today announced five presentations at the upcoming SITC 32nd Annual Meeting being held November 8-12, 2017 in National Harbor, Maryland.

November 8, 2017
·
5 min read
Business

Leading UK Drug Developer RxCelerate Opens First U.S. Base in Boston

RxCelerate announced today it has hired Laura Hamilton as Executive VP, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston.

November 8, 2017
·
5 min read
Business

Photocure ASA: Results for the Third Quarter of 2017

Photocure reported total group revenues of NOK 35.6 million in the third quarter of 2017 (35.2).

November 8, 2017
·
4 min read
BioMidwest

Sun BioPharma Announces Execution of Reverse Stock Split

The reverse stock split will be effective as of the close of business on November 7, 2017.

November 8, 2017
·
5 min read
Business

Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update

The Company reported a net loss of $32.1 million, or $0.25 per share, basic and diluted, for the nine-month period ended September 30, 2017.

November 8, 2017
·
11 min read
Business

VALNEVA Signs $39.6M IXIARO Supply Contract With U.S. Government

The new agreement will supplement the initial contract Valneva signed with the US military in March 2016 as the maximum quantity of doses allowed in the precedent contract was reached earlier than expected.

November 8, 2017
·
5 min read